These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 19502956

  • 1. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
    Ito R, Katano I, Kawai K, Hirata H, Ogura T, Kamisako T, Eto T, Ito M.
    Transplantation; 2009 Jun 15; 87(11):1654-8. PubMed ID: 19502956
    [Abstract] [Full Text] [Related]

  • 2. Development of human Graafian follicles following transplantation of human ovarian tissue into NOD/SCID/gammac null mice.
    Terada Y, Terunuma-Sato Y, Kakoi-Yoshimoto T, Hasegawa H, Ugajin T, Koyanagi Y, Ito M, Murakami T, Sasano H, Yaegashi N, Okamura K.
    Am J Reprod Immunol; 2008 Dec 15; 60(6):534-40. PubMed ID: 19032615
    [Abstract] [Full Text] [Related]

  • 3. T lymphocytes determine the development of xeno GVHD and of human hemopoiesis in NOD/SCID mice following human umbilical cord blood transplantation.
    Verlinden SF, Mulder AH, de Leeuw JP, van Bekkum DW.
    Stem Cells; 1998 Dec 15; 16 Suppl 1():205-17. PubMed ID: 11012164
    [Abstract] [Full Text] [Related]

  • 4. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
    Pino S, Brehm MA, Covassin-Barberis L, King M, Gott B, Chase TH, Wagner J, Burzenski L, Foreman O, Greiner DL, Shultz LD.
    Methods Mol Biol; 2010 Dec 15; 602():105-17. PubMed ID: 20012395
    [Abstract] [Full Text] [Related]

  • 5. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
    Ito R, Katano I, Ida-Tanaka M, Kamisako T, Kawai K, Suemizu H, Aiso S, Ito M.
    J Immunol; 2012 Nov 01; 189(9):4313-20. PubMed ID: 23018460
    [Abstract] [Full Text] [Related]

  • 6. [Establishment of an xenogeneic acute graft-versus-host disease model in NOD/SCID mice by engraftment of G-CSF mobilized human mononuclear cells].
    Gao L, Wang JM, Xie LN, Zhou H, Qiu HY.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb 01; 29(2):87-91. PubMed ID: 18681307
    [Abstract] [Full Text] [Related]

  • 7. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ, Shultz LD, Greiner DL, Burzenski LM, Gott B, Lyons BL, Rossini AA, Appel MC.
    Clin Immunol; 2004 Sep 01; 112(3):273-83. PubMed ID: 15308121
    [Abstract] [Full Text] [Related]

  • 8. Histological assessment of the sclerotic graft-versus-host response in the humanized RAG2-/-γc-/- mouse model.
    Hogenes MC, van Dorp S, van Kuik J, Monteiro FR, ter Hoeve N, van Dijk MR, Martens AC, de Weger RA.
    Biol Blood Marrow Transplant; 2012 Jul 01; 18(7):1023-35. PubMed ID: 22579931
    [Abstract] [Full Text] [Related]

  • 9. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A, Ishida T, Utsunomiya A, Sato F, Mori F, Yano H, Inagaki A, Suzuki S, Takino H, Ri M, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R.
    J Immunol; 2009 Oct 01; 183(7):4782-91. PubMed ID: 19748990
    [Abstract] [Full Text] [Related]

  • 10. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
    King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL.
    Clin Immunol; 2008 Mar 01; 126(3):303-14. PubMed ID: 18096436
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phytohemagglutinin-activated human T cells induce lethal graft-versus-host disease in cyclophosphamide and anti-CD122 conditioned NOD/SCID mice.
    Hu Y, Gu Y, Cui Q, Fu H, Sheng L, Wu K, Liu L, Fu S, Yu X, Huang H.
    Ann Hematol; 2012 Nov 01; 91(11):1803-12. PubMed ID: 22699803
    [Abstract] [Full Text] [Related]

  • 13. Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation.
    Fujii H, Luo ZJ, Kim HJ, Newbigging S, Gassas A, Keating A, Egeler RM.
    PLoS One; 2015 Nov 01; 10(7):e0133216. PubMed ID: 26176698
    [Abstract] [Full Text] [Related]

  • 14. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
    Cao T, Soto A, Zhou W, Wang W, Eck S, Walker M, Harriman G, Li L.
    Cell Immunol; 2009 Nov 01; 258(1):65-71. PubMed ID: 19410243
    [Abstract] [Full Text] [Related]

  • 15. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex.
    King MA, Covassin L, Brehm MA, Racki W, Pearson T, Leif J, Laning J, Fodor W, Foreman O, Burzenski L, Chase TH, Gott B, Rossini AA, Bortell R, Shultz LD, Greiner DL.
    Clin Exp Immunol; 2009 Jul 01; 157(1):104-18. PubMed ID: 19659776
    [Abstract] [Full Text] [Related]

  • 16. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice.
    Suemizu H, Hasegawa M, Kawai K, Taniguchi K, Monnai M, Wakui M, Suematsu M, Ito M, Peltz G, Nakamura M.
    Biochem Biophys Res Commun; 2008 Dec 05; 377(1):248-52. PubMed ID: 18840406
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive and real-time assessment of reconstructed functional human endometrium in NOD/SCID/gamma c(null) immunodeficient mice.
    Masuda H, Maruyama T, Hiratsu E, Yamane J, Iwanami A, Nagashima T, Ono M, Miyoshi H, Okano HJ, Ito M, Tamaoki N, Nomura T, Okano H, Matsuzaki Y, Yoshimura Y.
    Proc Natl Acad Sci U S A; 2007 Feb 06; 104(6):1925-30. PubMed ID: 17261813
    [Abstract] [Full Text] [Related]

  • 18. A Novel Xenogeneic Graft-Versus-Host Disease Model for Investigating the Pathological Role of Human CD4+ or CD8+ T Cells Using Immunodeficient NOG Mice.
    Ito R, Katano I, Kawai K, Yagoto M, Takahashi T, Ka Y, Ogura T, Takahashi R, Ito M.
    Am J Transplant; 2017 May 06; 17(5):1216-1228. PubMed ID: 27862942
    [Abstract] [Full Text] [Related]

  • 19. Cellular-based therapies to prevent or reduce thrombocytopenia.
    Pineault N, Boyer L.
    Transfusion; 2011 Nov 06; 51 Suppl 4():72S-81S. PubMed ID: 22074630
    [Abstract] [Full Text] [Related]

  • 20. Xenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype.
    Ali N, Flutter B, Sanchez Rodriguez R, Sharif-Paghaleh E, Barber LD, Lombardi G, Nestle FO.
    PLoS One; 2012 Nov 06; 7(8):e44219. PubMed ID: 22937164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.